Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.
2/1/2012 Int Arch Med. 2012 Feb 8;5:5. Rodriguez JP, Murphy MP, Hong S, Madrigal M, March KL, Minev B, Harman RJ, Chen CS, Timmons RB, Marleau AM, Riordan NH. Advancements in rheumatoid arthritis (RA) treatment protocols and introduction of targeted biological therapies have markedly improved patient outcomes, despite this, up to 50% of patients still…
Antigen-specific therapy of rheumatoid arthritis.
2/1/2008 Expert Opin Biol Ther. 2008 Feb;8(2):191-9 Ichim TE, Zheng X, Suzuki M, Kubo N, Zhang X, Min LR, Beduhn ME, Riordan NH, Inman RD, Min WP. Background: Immunotherapy offers the promise of antigen-specific suppression of pathological immune responses in conditions such as autoimmunity and organ transplantation. Substantial advances have been made in recent years…